AMICUS THERAPEUTICS, INC. — Director's Dealing 2015

Jul 9, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2015-07-07

Reporting Person: Doshi Dipal (SVP Strategy & Bus Dev)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-07-07	Common stock	M	12500	—	Acquired	12500	Direct
2015-07-07	Common stock	F	4544	$14.10	Disposed	7956	Direct
2015-07-08	Common stock	S	6250	$13.8703	Disposed	1706	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-07-07	Restricted stock units	$	M	12500	Acquired		Common Stock (12500)	Direct

Footnotes

F1: Restricted stock units convert into common stock on a one-for-one basis.

F2: The sales of shares of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 27, 2015.

F3: This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.74 to $14.00. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F4: On July 7, 2014, the reporting person was granted 25,000 restricted stock units, vesting in equal installments of 12,500 restricted stock units on July 7, 2015 and 12,500 restricted stock units on July 7, 2016.